Global H1N1 Vaccines Market Research Report 2021

Publisher Name :
Date: 11-Feb-2021
No. of pages: 99
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Intramuscular Vaccines

- Intranasal Vaccines

- Intradermal Vaccines

Segment by Application

- Influenza

- Meningococcal

- Cervical Cancer

- Pneumococcal

- Hepatitis

- Measles

- Mumps

- Rubella

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Abbott

- Baxter International

- Sanofi

- GSK

- Pfizer

- Mitsubishi Tanabe Pharma

- Hualan Biological Engineering

- Cipla

- Merck

- Sinovac Biotech

Global H1N1 Vaccines Market Research Report 2021

Table of Contents
1 H1N1 Vaccines Market Overview
1.1 Product Overview and Scope of H1N1 Vaccines
1.2 H1N1 Vaccines Segment by Type
1.2.1 Global H1N1 Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Intramuscular Vaccines
1.2.3 Intranasal Vaccines
1.2.4 Intradermal Vaccines
1.3 H1N1 Vaccines Segment by Application
1.3.1 H1N1 Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Cervical Cancer
1.3.5 Pneumococcal
1.3.6 Hepatitis
1.3.7 Measles
1.3.8 Mumps
1.3.9 Rubella
1.3.10 Others
1.4 Global H1N1 Vaccines Market Size Estimates and Forecasts
1.4.1 Global H1N1 Vaccines Revenue 2016-2027
1.4.2 Global H1N1 Vaccines Sales 2016-2027
1.4.3 H1N1 Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 H1N1 Vaccines Market Competition by Manufacturers
2.1 Global H1N1 Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global H1N1 Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global H1N1 Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers H1N1 Vaccines Manufacturing Sites, Area Served, Product Type
2.5 H1N1 Vaccines Market Competitive Situation and Trends
2.5.1 H1N1 Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest H1N1 Vaccines Players Market Share by Revenue
2.5.3 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 H1N1 Vaccines Retrospective Market Scenario by Region
3.1 Global H1N1 Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global H1N1 Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America H1N1 Vaccines Market Facts & Figures by Country
3.3.1 North America H1N1 Vaccines Sales by Country
3.3.2 North America H1N1 Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe H1N1 Vaccines Market Facts & Figures by Country
3.4.1 Europe H1N1 Vaccines Sales by Country
3.4.2 Europe H1N1 Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific H1N1 Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific H1N1 Vaccines Sales by Region
3.5.2 Asia Pacific H1N1 Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America H1N1 Vaccines Market Facts & Figures by Country
3.6.1 Latin America H1N1 Vaccines Sales by Country
3.6.2 Latin America H1N1 Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa H1N1 Vaccines Sales by Country
3.7.2 Middle East and Africa H1N1 Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global H1N1 Vaccines Historic Market Analysis by Type
4.1 Global H1N1 Vaccines Sales Market Share by Type (2016-2021)
4.2 Global H1N1 Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global H1N1 Vaccines Price by Type (2016-2021)
5 Global H1N1 Vaccines Historic Market Analysis by Application
5.1 Global H1N1 Vaccines Sales Market Share by Application (2016-2021)
5.2 Global H1N1 Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global H1N1 Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Baxter International Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GSK Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Corporation Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Mitsubishi Tanabe Pharma Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 Hualan Biological Engineering
6.6.1 Hualan Biological Engineering Corporation Information
6.6.2 Hualan Biological Engineering Description and Business Overview
6.6.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hualan Biological Engineering Product Portfolio
6.7.5 Hualan Biological Engineering Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Cipla Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Merck Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Sinovac Biotech
6.10.1 Sinovac Biotech Corporation Information
6.10.2 Sinovac Biotech Description and Business Overview
6.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Sinovac Biotech Product Portfolio
6.10.5 Sinovac Biotech Recent Developments/Updates
7 H1N1 Vaccines Manufacturing Cost Analysis
7.1 H1N1 Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of H1N1 Vaccines
7.4 H1N1 Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 H1N1 Vaccines Distributors List
8.3 H1N1 Vaccines Customers
9 H1N1 Vaccines Market Dynamics
9.1 H1N1 Vaccines Industry Trends
9.2 H1N1 Vaccines Growth Drivers
9.3 H1N1 Vaccines Market Challenges
9.4 H1N1 Vaccines Market Restraints
10 Global Market Forecast
10.1 H1N1 Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of H1N1 Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of H1N1 Vaccines by Type (2022-2027)
10.2 H1N1 Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of H1N1 Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of H1N1 Vaccines by Application (2022-2027)
10.3 H1N1 Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of H1N1 Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of H1N1 Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global H1N1 Vaccines Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global H1N1 Vaccines Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global H1N1 Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers H1N1 Vaccines Covered in This Study
Table 5. Global H1N1 Vaccines Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global H1N1 Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global H1N1 Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global H1N1 Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market H1N1 Vaccines Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers H1N1 Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers H1N1 Vaccines Product Type
Table 12. Global H1N1 Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global H1N1 Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H1N1 Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global H1N1 Vaccines Sales by Region (2016-2021) & (K MT)
Table 16. Global H1N1 Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global H1N1 Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America H1N1 Vaccines Sales by Country (2016-2021) & (K MT)
Table 19. North America H1N1 Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America H1N1 Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America H1N1 Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe H1N1 Vaccines Sales by Country (2016-2021) & (K MT)
Table 23. Europe H1N1 Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe H1N1 Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe H1N1 Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific H1N1 Vaccines Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific H1N1 Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific H1N1 Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific H1N1 Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America H1N1 Vaccines Sales by Country (2016-2021) & (K MT)
Table 31. Latin America H1N1 Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America H1N1 Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America H1N1 Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa H1N1 Vaccines Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa H1N1 Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa H1N1 Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa H1N1 Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global H1N1 Vaccines Sales (K MT) by Type (2016-2021)
Table 39. Global H1N1 Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global H1N1 Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global H1N1 Vaccines Revenue Share by Type (2016-2021)
Table 42. Global H1N1 Vaccines Price (USD/MT) by Type (2016-2021)
Table 43. Global H1N1 Vaccines Sales (K MT) by Application (2016-2021)
Table 44. Global H1N1 Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global H1N1 Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global H1N1 Vaccines Revenue Share by Application (2016-2021)
Table 47. Global H1N1 Vaccines Price (USD/MT) by Application (2016-2021)
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Business Overview
Table 50. Abbott H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Abbott H1N1 Vaccines Product
Table 52. Abbott Recent Developments/Updates
Table 53. Baxter International Corporation Information
Table 54. Baxter International Description and Business Overview
Table 55. Baxter International H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Baxter International H1N1 Vaccines Product
Table 57. Baxter International Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Sanofi H1N1 Vaccines Product
Table 62. Sanofi Recent Developments/Updates
Table 63. GSK Corporation Information
Table 64. GSK Description and Business Overview
Table 65. GSK H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. GSK H1N1 Vaccines Product
Table 67. GSK Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Pfizer H1N1 Vaccines Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Mitsubishi Tanabe Pharma Corporation Information
Table 74. Mitsubishi Tanabe Pharma Description and Business Overview
Table 75. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Mitsubishi Tanabe Pharma H1N1 Vaccines Product
Table 77. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 78. Hualan Biological Engineering Corporation Information
Table 79. Hualan Biological Engineering Description and Business Overview
Table 80. Hualan Biological Engineering H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Hualan Biological Engineering H1N1 Vaccines Product
Table 82. Hualan Biological Engineering Recent Developments/Updates
Table 83. Cipla Corporation Information
Table 84. Cipla Description and Business Overview
Table 85. Cipla H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Cipla H1N1 Vaccines Product
Table 87. Cipla Recent Developments/Updates
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Merck H1N1 Vaccines Product
Table 92. Merck Recent Developments/Updates
Table 93. Sinovac Biotech Corporation Information
Table 94. Sinovac Biotech Description and Business Overview
Table 95. Sinovac Biotech H1N1 Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Sinovac Biotech H1N1 Vaccines Product
Table 97. Sinovac Biotech Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. H1N1 Vaccines Distributors List
Table 101. H1N1 Vaccines Customers List
Table 102. H1N1 Vaccines Market Trends
Table 103. H1N1 Vaccines Growth Drivers
Table 104. H1N1 Vaccines Market Restraints
Table 105. Global H1N1 Vaccines Sales Forecast by Type (2022-2027) & (K MT)
Table 106. Global H1N1 Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 107. Global H1N1 Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global H1N1 Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global H1N1 Vaccines Sales Forecast by Application (2022-2027) & (K MT)
Table 110. Global H1N1 Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 111. Global H1N1 Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global H1N1 Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global H1N1 Vaccines Sales Forecast by Region (2022-2027) & (K MT)
Table 114. Global H1N1 Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 115. Global H1N1 Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global H1N1 Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of H1N1 Vaccines
Figure 2. Global H1N1 Vaccines Market Share by Type in 2020 & 2027
Figure 3. Intramuscular Vaccines Product Picture
Figure 4. Intranasal Vaccines Product Picture
Figure 5. Intradermal Vaccines Product Picture
Figure 6. Global H1N1 Vaccines Market Share by Application in 2020 & 2027
Figure 7. Influenza
Figure 8. Meningococcal
Figure 9. Cervical Cancer
Figure 10. Pneumococcal
Figure 11. Hepatitis
Figure 12. Measles
Figure 13. Mumps
Figure 14. Rubella
Figure 15. Others
Figure 16. Global H1N1 Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global H1N1 Vaccines Market Size 2016-2027 (US$ Million)
Figure 18. Global H1N1 Vaccines Sales 2016-2027 (K MT)
Figure 19. Global H1N1 Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. H1N1 Vaccines Sales Share by Manufacturers in 2020
Figure 21. Global H1N1 Vaccines Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest H1N1 Vaccines Players: Market Share by Revenue in 2020
Figure 23. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global H1N1 Vaccines Sales Market Share by Region (2016-2021)
Figure 25. Global H1N1 Vaccines Sales Market Share by Region in 2020
Figure 26. Global H1N1 Vaccines Revenue Market Share by Region (2016-2021)
Figure 27. Global H1N1 Vaccines Revenue Market Share by Region in 2020
Figure 28. U.S. H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E H1N1 Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of H1N1 Vaccines by Type (2016-2021)
Figure 53. Sales Market Share of H1N1 Vaccines by Application (2016-2021)
Figure 54. Sales Market Share of H1N1 Vaccines by Application in 2020
Figure 55. Revenue Share of H1N1 Vaccines by Application (2016-2021)
Figure 56. Revenue Share of H1N1 Vaccines by Application in 2020
Figure 57. Manufacturing Cost Structure of H1N1 Vaccines
Figure 58. Manufacturing Process Analysis of H1N1 Vaccines
Figure 59. H1N1 Vaccines Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Influenza Vaccines Market 2021 - 2027
    Published: 19-Apr-2021        Price: US 3450 Onwards        Pages: 275
    The number of persons being vaccinated with influenza vaccines worldwide will touch the figure of 500 Million by the year-end of 2027 Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries. Long–term Growth Projection:......
  • Global Avian Influenza Vaccines Sales Market Report 2021
    Published: 06-Apr-2021        Price: US 4000 Onwards        Pages: 139
    The global Avian Influenza Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avian Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Type H5 - Type H9 - ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Report 2021
    Published: 01-Apr-2021        Price: US 4000 Onwards        Pages: 134
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global 23-Valent Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type......
  • Global Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)
    Published: 31-Mar-2021        Price: US 2000 Onwards        Pages: 214
    Executive Summary Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively influence the sales of Coronavirus vaccine in the upcoming years. Moreover, the strong demand for coronavirus vaccine, the ongoing initiative initiatives by go......
  • 2020-2025 Global H1N1 Vaccines Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 30-Mar-2021        Price: US 3360 Onwards        Pages: 97
    This report elaborates the market size, market characteristics, and market growth of the H1N1 Vaccines industry, and breaks down according to the type, application, and consumption area of H1N1 Vaccines. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry re......
  • 2020-2025 Global Influenza Vaccine Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 25-Mar-2021        Price: US 3360 Onwards        Pages: 120
    Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... This report elaborates the market size, market characteristics, and market growth of the Influenza Vaccine industry, and breaks down according to the type, application, and consumption area of Influenza Vaccine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chap......
  • Global Encephalitis Vaccination Market Growth (Status and Outlook) 2021-2026
    Published: 22-Mar-2021        Price: US 3660 Onwards        Pages: 115
    According to this latest study, the 2021 growth of Encephalitis Vaccination will have significant change from previous year. By the most conservative estimates of global Encephalitis Vaccination market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1196.1 million in 2020. Over the next five years the Encephalitis Vaccination market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 1499.2 million by 2026. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2021-2026
    Published: 19-Mar-2021        Price: US 3660 Onwards        Pages: 137
    According to this latest study, the 2021 growth of 23-Valent Pneumococcal Polysaccharide Vaccine will have significant change from previous year. By the most conservative estimates of global 23-Valent Pneumococcal Polysaccharide Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2326.5 million in 2020. Over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 14.9% CAGR in terms of revenue, the g......
  • Global Encephalitis Vaccination Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 18-Mar-2021        Price: US 2980 Onwards        Pages: 87
    Snapshot The global Encephalitis Vaccination market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Encephalitis Vaccination by product, region and application, in addition, this report introduces market competition situation among the vendor......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs